| Indicators | Browse All

Drugs Made In America Acquisition Corp. (DMAAU)

Financial Services | Shell Companies | New York, United States | NasdaqGM
10.72 USD

Short-term:⯪☆☆☆☆Long-term:★★⯪☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 6:23 a.m. EDT

The immediate outlook is severely clouded by the company's status as a shell entity with a negative book value and massive debt obligations relative to its negligible cash reserves. While the recent price action shows a flat, stagnant pattern hovering near the $10.70 mark, the underlying financial structure presents a significant risk of dilution or liquidation rather than organic growth. The lack of any dividend history confirms that investors cannot rely on income, leaving them entirely exposed to speculative SPAC merger outcomes which have yet to materialize. Consequently, there is no compelling case for a near-term bullish entry given the precarious balance sheet and the absence of operational cash flow.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.016468
AutoTheta0.017058
AutoETS0.017687
MSTL0.018025

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 53%
H-stat 2670.85
Ljung-Box p 0.000
Jarque-Bera p 0.000
Excess Kurtosis 0.91
Attribute Value
Sector Financial Services

Info Dump

Attribute Value
52 Week Change 0.03176129
Address1 420 Lexington Avenue
Address2 Suite 1402
All Time High 12.5
All Time Low 10.0
Ask 10.13
Ask Size 167
Average Daily Volume10 Day 40
Average Daily Volume3 Month 653
Average Volume 653
Average Volume10Days 40
Bid 10.54
Bid Size 1
Book Value -0.219
City New York
Country United States
Crypto Tradeable 0
Currency USD
Current Price 10.72
Current Ratio 0.03
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 10.72
Day Low 10.72
Display Name Drugs Made In America
Earnings Growth 0.188
Earnings Quarterly Growth 0.571
Earnings Timestamp End 1,747,771,200
Earnings Timestamp Start 1,747,771,200
Ebitda Margins 0.0
Enterprise Value 361,532,896
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 10.77486
Fifty Day Average Change -0.054860115
Fifty Day Average Change Percent -0.005091492
Fifty Two Week Change Percent 3.1761289
Fifty Two Week High 12.5
Fifty Two Week High Change -1.7799997
Fifty Two Week High Change Percent -0.14239998
Fifty Two Week Low 10.3
Fifty Two Week Low Change 0.42000008
Fifty Two Week Low Change Percent 0.040776707
Fifty Two Week Range 10.3 - 12.5
Financial Currency USD
First Trade Date Milliseconds 1,738,074,600,000
Float Shares 27,895,541
Full Exchange Name NasdaqGM
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Held Percent Insiders 0.17878
Held Percent Institutions 0.015420001
Industry Shell Companies
Industry Disp Shell Companies
Industry Key shell-companies
Ipo Expected Date 2,025-01-28
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Long Name Drugs Made In America Acquisition Corp.
Market us_market
Market State PREPRE
Max Age 86,400
Message Board Id finmb_1889535116
Most Recent Quarter 1,774,915,200
Net Income To Common 6,656,559
Next Fiscal Year End 1,798,675,200
Open 10.72
Operating Cashflow -379,193
Operating Margins 0.0
Phone 646 726 7074
Previous Close 10.72
Price Hint 2
Price To Book -48.94977
Profit Margins 0.0
Quick Ratio 0.03
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0
Regular Market Change Percent 0.0
Regular Market Day High 10.72
Regular Market Day Low 10.72
Regular Market Day Range 10.72 - 10.72
Regular Market Open 10.72
Regular Market Previous Close 10.72
Regular Market Price 10.72
Regular Market Time 1,783,540,800
Regular Market Volume 406
Sand P52 Week Change 0.20847368
Sector Financial Services
Sector Disp Financial Services
Sector Key financial-services
Shares Outstanding 29,171,400
Shares Short 983
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 1,257
Short Name Drugs Made In America Acquisiti
Short Ratio 1.53
Source Interval 15
State NY
Symbol DMAAU
Total Cash 14,887
Total Cash Per Share 0.0
Total Debt 100,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 10.577471
Two Hundred Day Average Change 0.14252949
Two Hundred Day Average Change Percent 0.013474817
Type Disp Equity
Volume 406
Zip 10,170